全文获取类型
收费全文 | 92篇 |
免费 | 0篇 |
国内免费 | 1篇 |
专业分类
系统科学 | 1篇 |
理论与方法论 | 1篇 |
现状及发展 | 42篇 |
研究方法 | 6篇 |
综合类 | 38篇 |
自然研究 | 5篇 |
出版年
2018年 | 2篇 |
2016年 | 3篇 |
2012年 | 2篇 |
2011年 | 6篇 |
2008年 | 2篇 |
2007年 | 3篇 |
2006年 | 3篇 |
2005年 | 8篇 |
2004年 | 4篇 |
2002年 | 1篇 |
2001年 | 6篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1987年 | 1篇 |
1986年 | 1篇 |
1983年 | 1篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 3篇 |
1976年 | 2篇 |
1975年 | 7篇 |
1974年 | 2篇 |
1972年 | 8篇 |
1971年 | 4篇 |
1970年 | 3篇 |
1966年 | 1篇 |
1964年 | 1篇 |
1962年 | 1篇 |
1961年 | 2篇 |
1959年 | 1篇 |
排序方式: 共有93条查询结果,搜索用时 15 毫秒
31.
Summary Light flashes evoke an increased release of radioactivity in vitro from rabbit retinas preloaded with (3H)-GABA in vivo. Constant light does not affect the release. No light evoked release can be demonstrated from the glia. Pentobarbitone and AOAA depress the evoked release. The results are consistent with GABA being a retinal neurotransmitter, most likely in a class of amacrines.This work was supported by grants from the Swedish Medical Research Council (project 04X2321), The Faculty of Medicine, University of Lund, Royal Physiographic Society. 相似文献
32.
33.
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome 总被引:10,自引:0,他引:10
Zimprich A Grabowski M Asmus F Naumann M Berg D Bertram M Scheidtmann K Kern P Winkelmann J Müller-Myhsok B Riedel L Bauer M Müller T Castro M Meitinger T Strom TM Gasser T 《Nature genetics》2001,29(1):66-69
The dystonias are a common clinically and genetically heterogeneous group of movement disorders. More than ten loci for inherited forms of dystonia have been mapped, but only three mutated genes have been identified so far. These are DYT1, encoding torsin A and mutant in the early-onset generalized form, GCH1 (formerly known as DYT5), encoding GTP-cyclohydrolase I and mutant in dominant dopa-responsive dystonia, and TH, encoding tyrosine hydroxylase and mutant in the recessive form of the disease. Myoclonus-dystonia syndrome (MDS; DYT11) is an autosomal dominant disorder characterized by bilateral, alcohol-sensitive myoclonic jerks involving mainly the arms and axial muscles. Dystonia, usually torticollis and/or writer's cramp, occurs in most but not all affected patients and may occasionally be the only symptom of the disease. In addition, patients often show prominent psychiatric abnormalities, including panic attacks and obsessive-compulsive behavior. In most MDS families, the disease is linked to a locus on chromosome 7q21 (refs. 11-13). Using a positional cloning approach, we have identified five different heterozygous loss-of-function mutations in the gene for epsilon-sarcoglycan (SGCE), which we mapped to a refined critical region of about 3.2 Mb. SGCE is expressed in all brain regions examined. Pedigree analysis shows a marked difference in penetrance depending on the parental origin of the disease allele. This is indicative of a maternal imprinting mechanism, which has been demonstrated in the mouse epsilon-sarcoglycan gene. 相似文献
34.
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 总被引:49,自引:0,他引:49
Herzig S Long F Jhala US Hedrick S Quinn R Bauer A Rudolph D Schutz G Yoon C Puigserver P Spiegelman B Montminy M 《Nature》2001,413(6852):179-183
When mammals fast, glucose homeostasis is achieved by triggering expression of gluconeogenic genes in response to glucagon and glucocorticoids. The pathways act synergistically to induce gluconeogenesis (glucose synthesis), although the underlying mechanism has not been determined. Here we show that mice carrying a targeted disruption of the cyclic AMP (cAMP) response element binding (CREB) protein gene, or overexpressing a dominant-negative CREB inhibitor, exhibit fasting hypoglycaemia [corrected] and reduced expression of gluconeogenic enzymes. CREB was found to induce expression of the gluconeogenic programme through the nuclear receptor coactivator PGC-1, which is shown here to be a direct target for CREB regulation in vivo. Overexpression of PGC-1 in CREB-deficient mice restored glucose homeostasis and rescued expression of gluconeogenic genes. In transient assays, PGC-1 potentiated glucocorticoid induction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limiting enzyme in gluconeogenesis. PGC-1 promotes cooperativity between cyclic AMP and glucocorticoid signalling pathways during hepatic gluconeogenesis. Fasting hyperglycaemia is strongly correlated with type II diabetes, so our results suggest that the activation of PGC-1 by CREB in liver contributes importantly to the pathogenesis of this disease. 相似文献
35.
Kévin Baranger Yannick Marchalant Amandine E. Bonnet Nadine Crouzin Alex Carrete Jean-Michel Paumier Nathalie A. Py Anne Bernard Charlotte Bauer Eliane Charrat Katrin Moschke Mothoharu Seiki Michel Vignes Stefan F. Lichtenthaler Frédéric Checler Michel Khrestchatisky Santiago Rivera 《Cellular and molecular life sciences : CMLS》2016,73(1):217-236
36.
Ferrón SR Charalambous M Radford E McEwen K Wildner H Hind E Morante-Redolat JM Laborda J Guillemot F Bauer SR Fariñas I Ferguson-Smith AC 《Nature》2011,475(7356):381-385
The gene for the atypical NOTCH ligand delta-like homologue 1 (Dlk1) encodes membrane-bound and secreted isoforms that function in several developmental processes in vitro and in vivo. Dlk1, a member of a cluster of imprinted genes, is expressed from the paternally inherited chromosome. Here we show that mice that are deficient in Dlk1 have defects in postnatal neurogenesis in the subventricular zone: a developmental continuum that results in depletion of mature neurons in the olfactory bulb. We show that DLK1 is secreted by niche astrocytes, whereas its membrane-bound isoform is present in neural stem cells (NSCs) and is required for the inductive effect of secreted DLK1 on self-renewal. Notably, we find that there is a requirement for Dlk1 to be expressed from both maternally and paternally inherited chromosomes. Selective absence of Dlk1 imprinting in both NSCs and niche astrocytes is associated with postnatal acquisition of DNA methylation at the germ-line-derived imprinting control region. The results emphasize molecular relationships between NSCs and the niche astrocyte cells of the microenvironment, identifying a signalling system encoded by a single gene that functions coordinately in both cell types. The modulation of genomic imprinting in a stem-cell environment adds a new level of epigenetic regulation to the establishment and maintenance of the niche, raising wider questions about the adaptability, function and evolution of imprinting in specific developmental contexts. 相似文献
37.
Martin Bauer 《Systemic Practice and Action Research》1991,4(3):181-196
This paper examines the credibility of the deficit model of resistance to change in a case study on office automation. A functional analysis of resistance to change is conducted using narrative interviews and documentary analysis. Resistance to change is shown to occur and to affect the implementation process: resistance is identified as a useful source of information, directing the attention of the change agency to improve hardware, software, and the organization. User attitudes were found to change: global skepticism developed into critical acceptance of the office system. The decision-making criteria changed during the 3-year period of the case study. More criteria were used, with user-friendliness becoming more prominent in the decision criteria. The case highlights some limitations of Lewinian field theory in studying resistance to change. Systems theory may provide a more useful framework, organized around the principle that resistance to change is a functional selfmonitoring subsystem guiding the internal adjustment of the changing organization and thus securing effectiveness. This approach may have wider implications for the analysis of social change. 相似文献
38.
A single origin of phenylketonuria in Yemenite Jews 总被引:12,自引:0,他引:12
S Avigad B E Cohen S Bauer G Schwartz M Frydman S L Woo Y Niny Y Shiloh 《Nature》1990,344(6262):168-170
Phenylketonuria (PKU) is a metabolic disease caused by recessive mutations of the gene encoding the hepatic enzyme phenylalanine hydroxylase (PAH). The incidence of PKU varies widely across different geographic areas, and is highest (about 1 in 5,000 live births) in Ireland and western Scotland, and among Yemenite Jews. A limited number of point mutations account for most of the PKU cases in the European population. Here we report that a single molecular defect--a deletion spanning the third exon of the PAH gene--is responsible for all the PKU cases among the Yemenite Jews. Examination of a random sample of Yemenite Jews using a molecular probe that detects the carriers of this deletion indicated a high frequency of the defective gene in this community. Although the deleted PAH gene was traced to 25 different locations throughout Yemen, family histories and official documents of the Yemenite Jewish community showed that the common ancestor of all the carriers of this genetic defect lived in San'a, the capital of Yemen, before the eighteenth century. 相似文献
39.
J. E. Bauer N. Gerber R. K. Lynn R. G. Smith R. M. Thompson 《Cellular and molecular life sciences : CMLS》1976,32(8):1032-1033
Summary An N-glucuronide metabolite of carbamazepine was identified in the bile of the isolated perfused rat liver by means of permethylation, gas chromatography and mass spectrometry.This research was supported by grants from the National Institutes of Health (Nos. N01-NS-5-2328, AM-17665) and the James Whitcomb Riley Memorial Association (No. 74-15) and a grant from the Epilepsy, Foundation of America. 相似文献
40.
Yagoda N von Rechenberg M Zaganjor E Bauer AJ Yang WS Fridman DJ Wolpaw AJ Smukste I Peltier JM Boniface JJ Smith R Lessnick SL Sahasrabudhe S Stockwell BR 《Nature》2007,447(7146):864-868
Therapeutics that discriminate between the genetic makeup of normal cells and tumour cells are valuable for treating and understanding cancer. Small molecules with oncogene-selective lethality may reveal novel functions of oncoproteins and enable the creation of more selective drugs. Here we describe the mechanism of action of the selective anti-tumour agent erastin, involving the RAS-RAF-MEK signalling pathway functioning in cell proliferation, differentiation and survival. Erastin exhibits greater lethality in human tumour cells harbouring mutations in the oncogenes HRAS, KRAS or BRAF. Using affinity purification and mass spectrometry, we discovered that erastin acts through mitochondrial voltage-dependent anion channels (VDACs)--a novel target for anti-cancer drugs. We show that erastin treatment of cells harbouring oncogenic RAS causes the appearance of oxidative species and subsequent death through an oxidative, non-apoptotic mechanism. RNA-interference-mediated knockdown of VDAC2 or VDAC3 caused resistance to erastin, implicating these two VDAC isoforms in the mechanism of action of erastin. Moreover, using purified mitochondria expressing a single VDAC isoform, we found that erastin alters the permeability of the outer mitochondrial membrane. Finally, using a radiolabelled analogue and a filter-binding assay, we show that erastin binds directly to VDAC2. These results demonstrate that ligands to VDAC proteins can induce non-apoptotic cell death selectively in some tumour cells harbouring activating mutations in the RAS-RAF-MEK pathway. 相似文献